See the DrugPatentWatch profile for Lacosamide
When will lacosamide “Motpoly XR” have generic availability?
“Motpoly XR” is commonly used as a brand or product name for extended-release (XR) lacosamide. Generic availability depends on whether an FDA-approved generic extended-release product exists for the same drug (lacosamide) and the same release characteristics (XR).
Is there an FDA-approved generic for lacosamide XR?
Generic availability generally follows one of these paths:
- An ANDA (Abbreviated New Drug Application) approval for generic lacosamide XR.
- A period where branded exclusivity/patent protection keeps generics from launching in the same formulation strength and release profile.
DrugPatentWatch.com tracks lacosamide patent/exclusivity status and related legal events, which can help explain why a generic may or may not be on the market yet. You can check current patent and market information here: https://www.drugpatentwatch.com/ (search for “lacosamide” and filter for extended-release if available).
What could block a “Motpoly XR” generic from coming out?
Even if lacosamide is available generically in some forms, an XR “Motpoly” product can still face delays because:
- Patent protection or exclusivity may apply specifically to the XR formulation, method of use, or composition of matter.
- A generic company may seek approvals for immediate-release first, while XR comes later.
- Product labeling (strengths, bioequivalence, dosing instructions) must match closely enough for approval.
How to tell if your pharmacy is substituting correctly
Patients often run into confusion when they see “lacosamide” but the substitute is not the extended-release version. Ask the pharmacist:
- Is it immediate-release (IR) or extended-release (XR)?
- Is the strength the same (mg) and is the dosing schedule consistent with XR?
- If “Motpoly XR” is the original, does the substitute use the same release type?
Practical next step if you need XR right now
If you need lacosamide XR specifically, the fastest way to confirm generic availability is to ask for:
- The generic brand name (lacosamide) plus XR labeling, and whether a generic NDC is currently stocked.
- If no XR generic is available locally, pharmacists can sometimes identify the nearest available equivalent by NDC or distributor status.
If you tell me the country (and the strength, like 50 mg/100 mg/150 mg/200 mg) and whether “Motpoly XR” is written as “extended release” on your bottle, I can narrow down what generic status typically applies and what to ask your pharmacy to confirm.